Rajab Mardani

794 total citations
20 papers, 541 citations indexed

About

Rajab Mardani is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Rajab Mardani has authored 20 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Rajab Mardani's work include COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Vitamin D Research Studies (2 papers). Rajab Mardani is often cited by papers focused on COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Vitamin D Research Studies (2 papers). Rajab Mardani collaborates with scholars based in Iran, United States and South Africa. Rajab Mardani's co-authors include Nayebali Ahmadi, Seyed Dawood Mousavi Nasab, Alireza Gholami, Fatemeh Zali, Abbas Ahmadi Vasmehjani, Hooman Kaghazian, Maasumeh Kaviani, Seyed Mohammad Gheibihayat, Simona Bo and Amirhossein Sahebkar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Cellular Physiology and Clinica Chimica Acta.

In The Last Decade

Rajab Mardani

16 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rajab Mardani Iran 10 217 157 83 73 72 20 541
Shixue Dai China 12 176 0.8× 212 1.4× 96 1.2× 28 0.4× 46 0.6× 28 742
Xin Liao China 16 183 0.8× 338 2.2× 196 2.4× 86 1.2× 138 1.9× 68 873
Jia Shi China 14 145 0.7× 209 1.3× 93 1.1× 16 0.2× 73 1.0× 39 575
Zhicheng Zhang China 13 212 1.0× 143 0.9× 73 0.9× 15 0.2× 108 1.5× 41 605
Jiraphun Jittikoon Thailand 14 151 0.7× 133 0.8× 29 0.3× 26 0.4× 68 0.9× 51 614
Duoduo Han China 12 229 1.1× 219 1.4× 45 0.5× 18 0.2× 77 1.1× 16 627
Yudong Peng China 14 328 1.5× 239 1.5× 172 2.1× 34 0.5× 203 2.8× 25 895
Margaret Zhou United States 10 98 0.5× 270 1.7× 67 0.8× 18 0.2× 50 0.7× 28 700
Hongquan Guan China 11 334 1.5× 280 1.8× 203 2.4× 28 0.4× 210 2.9× 15 794

Countries citing papers authored by Rajab Mardani

Since Specialization
Citations

This map shows the geographic impact of Rajab Mardani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajab Mardani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajab Mardani more than expected).

Fields of papers citing papers by Rajab Mardani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajab Mardani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajab Mardani. The network helps show where Rajab Mardani may publish in the future.

Co-authorship network of co-authors of Rajab Mardani

This figure shows the co-authorship network connecting the top 25 collaborators of Rajab Mardani. A scholar is included among the top collaborators of Rajab Mardani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajab Mardani. Rajab Mardani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mardani, Rajab, et al.. (2025). Oxidized Mannan: A Novel Adjuvant Candidate for Enhancing Immune Responses in Veterinary Rabies Vaccine. Chonnam Medical Journal. 61(2). 84–84.
2.
Kaghazian, Hooman, et al.. (2025). Biopharmaceutical Analysis by HPLC: Practices and Challenges. Chonnam Medical Journal. 61(1). 19–19. 1 indexed citations
3.
Mardani, Rajab & Maryam Shahali. (2024). Prediction of atherosclerosis in severe COVID-19 patients with CD16 and CD18 markers and inflammatory factors. Clinica Chimica Acta. 558. 118847–118847.
4.
Shahali, Maryam, et al.. (2024). Biochemical Risk Factors of Atherosclerosis in Patients with Severe and Non-severe COVID-19. Archives of Clinical Infectious Diseases. 19(4).
6.
Zali, Fatemeh, Rajab Mardani, Mohammad Farahmand, et al.. (2022). Predictive Value Alteration of Laboratory Routine and Ferritin/Transferrin Ratio in Monitoring of COVID-19 Patients. Clinical Laboratory. 68(10/2022). 2 indexed citations
7.
Mardani, Rajab, Zabihollah Shoja, Fatemeh Zali, et al.. (2021). Association between serum inflammatory parameters and the disease severity in COVID‐19 patients. Journal of Clinical Laboratory Analysis. 36(1). e24162–e24162. 15 indexed citations
8.
Taghizadeh, Eskandar, et al.. (2021). Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update. Biochemical Genetics. 60(2). 453–481. 6 indexed citations
9.
Mardani, Rajab, Michael R. Hamblin, Mohsen Taghizadeh, et al.. (2020). Nanomicellar-curcumin exerts its therapeutic effects via affecting angiogenesis, apoptosis, and T cells in a mouse model of melanoma lung metastasis. Pathology - Research and Practice. 216(9). 153082–153082. 50 indexed citations
10.
Mardani, Rajab, et al.. (2020). Association of vitamin D with the modulation of the disease severity in COVID-19. Virus Research. 289. 198148–198148. 51 indexed citations
11.
Mardani, Rajab, Eskandar Taghizadeh, Mohammad Reza Karimzadeh, et al.. (2020). A novel variant in C5ORF42 gene is associated with Joubert syndrome. Molecular Biology Reports. 47(5). 4099–4103. 2 indexed citations
12.
Mardani, Rajab, Mohsen Taghizadeh, Amir Ghaderi, et al.. (2020). Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways. Journal of Molecular Neuroscience. 70(10). 1471–1483. 53 indexed citations
13.
Mardani, Rajab, Abbas Ahmadi Vasmehjani, Fatemeh Zali, et al.. (2020). Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study.. SHILAP Revista de lepidopterología. 8(1). e43–e43. 173 indexed citations
14.
Mardani, Rajab, Fatemeh Zali, Abbas Ahmadi Vasmehjani, et al.. (2020). Neutrophil to lymphocyte ratio and C-reactive protein level as prognostic markers in mild versus severe COVID-19 patients.. PubMed. 13(4). 361–366. 15 indexed citations
15.
Nasab, Seyed Dawood Mousavi, Fatemeh Zali, Hooman Kaghazian, et al.. (2020). Prevalence of astrovirus, adenovirus, and sapovirus infections among Iranian children with acute gastroenteritis.. PubMed. 13(Suppl1). S122–S127. 14 indexed citations
16.
Abdolmaleki, Fereshte, Petri T. Kovanen, Rajab Mardani, et al.. (2019). Resolvins: Emerging Players in Autoimmune and Inflammatory Diseases. Clinical Reviews in Allergy & Immunology. 58(1). 82–91. 70 indexed citations
17.
Nasab, Seyed Dawood Mousavi, Abbas Ahmadi Vasmehjani, Hooman Kaghazian, et al.. (2019). Association of IL28B (IFNL3) rs12979860 mRNA levels, viral load, and liver function among HCV genotype 1a patients.. PubMed. 12(Suppl1). S156–S162. 4 indexed citations
18.
Mardani, Rajab, et al.. (2019). Pancreatic β‐cell regeneration: From molecular mechanisms to therapy. Journal of Cellular Biochemistry. 120(9). 14189–14200. 4 indexed citations
19.
Mardani, Rajab, et al.. (2018). MicroRNA in leukemia: Tumor suppressors and oncogenes with prognostic potential. Journal of Cellular Physiology. 234(6). 8465–8486. 66 indexed citations
20.
Taghizadeh, Eskandar, et al.. (2018). Molecular mechanisms, prevalence, and molecular methods for familial combined hyperlipidemia disease: A review. Journal of Cellular Biochemistry. 120(6). 8891–8898. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026